Prostate Cancer Drug Shortage Raises Concerns Among Doctors

Doctors are concerned about a shortage of the last-resort drug, radium-223, used to treat advanced prostate cancer. The drug is in short supply due to production issues, and some patients are being forced to switch to less effective treatments. The shortage is expected to last until at least the end of the year, and doctors are urging the pharmaceutical company to increase production to meet demand.